GlassScriptPhysician profile
Shelley Loomstein
NPI 1316163900
$785.97
in general payments reported to CMS, 2019-2025
18 companies · $50.79 in 2025
The $50.79 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $220 · 2023: $198 · 2024: $149 · 2025: $50.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $168.32 | 2021-2023 | |
| Glaxosmithkline, LLC. | $142.80 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $108.50 | 2022-2024 | Ozempic, Rybelsus |
| Biohaven Pharmaceuticals, INC. | $65.48 | 2021 | |
| Medtronic, INC. | $33.09 | 2022-2023 | Venaseal |
| Antares Pharma, INC. | $32.21 | 2022-2024 | Xyosted |
| Pfizer INC. | $27.40 | 2024 | |
| Boston Scientific Corporation | $26.22 | 2023 | Wavewriter Alpha Prime 16 |
| Corium, LLC | $23.17 | 2023 | Azstarys |
| Siemens Medical Solutions USA, INC. | $22.95 | 2022 | |
| Abbott Laboratories | $20.53 | 2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $20.30 | 2024 | Airsupra |
| Idorsia Pharmaceuticals US INC | $18.59 | 2023 | Quviviq |
| Genentech USA, INC. | $17.53 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.33 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $15.01 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.71 | 2025 | |
| Lilly USA, LLC | $12.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Loomstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.